This federal contract award is for the delivery of Ozempic, a medication used to manage diabetes, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $41,357.98, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 11, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation indicated. AmerisourceBergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/11/25, 9:53 AM